Ultimately, strategies involving ST3GAL5 and ST8SIA1 overexpression, or inhibition of ST3GAL6, FUT4 and FUT7, could offer new therapeutic avenues for bladder cancer. This evidence concerns the gene ST8SIA1 and urinary bladder carcinoma.